Mantis Biotech: Revolutionizing Biomedicine with Synthetic Datasets

Mantis Biotech, a New York-based startup, is leveraging large language models and synthetic datasets to create digital twins of human anatomy, physiology, and behavior. Their platform, which integrates data from various sources and validates it using LLMs, is revolutionizing drug discovery and diagnostics, particularly for rare diseases where data is scarce. With a recent $7.4 million seed funding round, Mantis is expanding into preventative care and pharma trials, aiming to transform how we model human health.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
[email protected]

This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].

View sources & latest updates:
https://sources.thednn.ai/56699521598be680